Psychedelic Therapy Training Program (PTTP)
This course is currently still being developed by the University of Pennsylvania School of Nursing and the Columbia University School of Social Work.
Provider
Details
Enrollment
Upcoming Cohort
Start date: September 1, 2025
Course Overview
Funded by a $1 million grant, the course aims to prepare social workers and nurses for the emerging field of psychedelic-assisted therapy, which is on the cusp of FDA approval. The curriculum, designed to be comprehensive and adaptable, will initially be piloted at Penn Nursing and Columbia's School of Social Work, with plans for broader dissemination. The course not only equips healthcare professionals with the skills and knowledge to administer this innovative form of treatment but also addresses the larger goal of improving access to safe and affordable mental health care.
The course is particularly timely given the current mental health crisis and the fast-track status granted to psychedelic therapies for various conditions, including depression, anxiety, and PTSD. It offers associated practicums in psychedelic research, ketamine clinics, and other clinical settings, ensuring participants receive hands-on experience. By focusing on best practices and leveraging social workers' and nurses' complementary skill sets, the course aims to meet the anticipated demand for trained practitioners in this field, thereby minimizing bottlenecks and ensuring a diverse, highly qualified workforce.
About the Provider
The Penn Psychedelics Collaborative at the University of Pennsylvania is a multi-school consortium of researchers, clinicians, and faculty advancing transdisciplinary psychedelic science across Penn Medicine and Penn Nursing, including clinical trials of MDMA-assisted therapy and psilocybin research. Penn researchers are also leading the development of bioethical guidelines for psychedelic-assisted therapy and community implementation frameworks.
View University of Pennsylvania profileCourse Details
- Price$5,000
- FormatLive Classes
- Lifecycle statusActive
- Skillspsychedelic therapymental health careFDA approval processinterdisciplinary collaborationethical considerationsclinical practicumpatient assessmenttreatment planninghealth equity
- Categories
Related Courses
View all coursesAdd Spravato® to Your Practice with Our 8-Phases Implementation Roadmap
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Are Ketamine Clinics Paving the Way for Legal Psychedelic Therapy?
By Double Blind
An article examining whether ketamine clinics could serve as a model for future legal psychedelic therapy. It discusses current ketamine clinic practices, emerging regulation questions, and how clinics are preparing for MDMA and psilocybin services.
Certificate in Psychedelic-Assisted Therapies & Research | Ciisciis Logociis Logo
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.